<DOC>
	<DOCNO>NCT01967498</DOCNO>
	<brief_summary>The purpose double-blind , placebo control study test hypothesis montelukast therapy might associate improved hearing certain sub population child suffer OME .</brief_summary>
	<brief_title>Montelukast Children With Chronic Otitis Media With Effusion ( COME ) : A Double-blind , Placebo-controlled Study</brief_title>
	<detailed_description>Chronic otitis medium effusion common problem child sometimes cause hearing impairment may affect language development quality life child . The standard treatment surgical insertion ventilation tube . In pediatric population procedure preform general anesthesia associate quite possible complication . In study examine effect conservative treatment montelukast resolution effusion without surgical treatment . Montelukast selective leukotriene receptor antagonist widely use child asthma1 . Allergic rhinitis child one approve indication Montelukast . Montelukast 's effect OME study several previous study . In 2004 study Combs JT2 show efficacy 49 % Montelukast clearing persistent OME post-AOM . This study direct patient chronic OME use audiometry endpoint . Another study 2005 Balatsouras DG study effect montelukast OME child suffer co-existing asthma . The rate OME resolution one month treatment 60 % oppose 36 % control group . The endpoint study OME audiometry result . There additional followup . In 2010 Schoem SR begin randomize control double blind study test effect montelukast child confirm OME 2 month . Montelukast give one month . Although goal recruit 120 child , study halt 38 treated statistical trend show positive effect compare placebo group . An additional study publish 2007 perform RCT 77 child prove drug 's effectiveness treatment OME . This study publish abstract detail hear inclusion criterion give . Montelukast proven effective resolve experimental OME rat model although oppose methylpresnisone reduce submucosal neutrophil infiltrate . The purpose double-blind , placebo control study test hypothesis montelukast therapy might associate improved hearing certain sub population child suffer OME .</detailed_description>
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Deafness</mesh_term>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Otitis Media Effusion</mesh_term>
	<mesh_term>Hearing Loss , Conductive</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Documented persistent OME least 3 month ( otoscopy audiometry tympanometry ) Patients age 210 evaluated VT surgery Tympanogram type B A conductive hearing loss great 20 DB Otoscopy confirm middle ear effusion previous adenoidectomy tonsillectomy history ear surgery cleft palate , Down 's syndrome , congenital , malformation ear cholesteatoma Sensoneural hearing loss Allergy montelukast Moderate Severe OSA require surgery sooner 3 month</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>chronic otitis medium effusion</keyword>
	<keyword>conductive hearing loss</keyword>
</DOC>